Rapport Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders. The company's lead product candidate is receptor...
24 insider purchases on record · latest filing 2025-09-15.
Insiders have also filed 82 sale transactions at RAPP.